The research, led by Jing Huo, Yong Dou, and Yong Sun of the Fourth People’s Hospital of Lu’an in Anhui, China, together with colleagues at the Second and First Hospitals of Anhui Medical University, took a deliberately unconventional approach to a familiar imaging problem. Rather than asking a radiologist to eyeball suspicious features, the team applied radiomics, a technique that converts medical images into hundreds of quantitative measurements of pixel intensity, texture, and spatial pattern. These features, invisible to human perception, can then be fed into statistical and machine learning models that learn to associate specific imaging signatures with biological behavior, in this case the presence of lymph node metastasis confirmed after surgery.

What distinguishes this study from much of the radiomics literature is its insistence on looking at more than one region of interest. Most radiomics studies of thyroid nodules extract features from the whole tumor, treating the lesion as a single homogeneous object. But tumors are not homogeneous. Papillary thyroid carcinomas contain biologically distinct compartments, some densely cellular, some fibrotic, some necrotic or hemorrhagic, each with its own ultrasound appearance. The Chinese team therefore constructed not one but five regions from each patient’s preoperative ultrasound: the entire tumor, three intratumoral habitat subregions generated by clustering algorithms that partition the tumor into zones of similar pixel behavior, and a three-millimeter rim of tissue immediately surrounding the tumor, the peritumoral region, where invading cancer cells first make contact with normal thyroid parenchyma.

The concept behind habitat imaging borrows from ecology. Just as an ecosystem contains distinct niches, a tumor contains microenvironments defined by blood supply, oxygen tension, and cell density, and these microenvironments leave fingerprints on imaging. By clustering voxels according to their signal characteristics, the researchers could isolate these habitats without any invasive biopsy. Meanwhile, the peritumoral region captures a different kind of information: the tumor’s interaction with its surroundings, including desmoplastic reaction, inflammatory infiltration, and microscopic invasion that extends beyond the visible border. Conventional whole-tumor analysis averages all of this away; the multi-region approach preserves it.

To test whether this added complexity actually buys diagnostic power, the team enrolled 390 patients with papillary thyroid carcinoma, splitting them into a training set and a testing set at a ratio of seven to three. Models were built separately for each region, then combined into a radiomics fusion model, and finally merged with clinical variables into a clinic-radiomics combined model. Performance was measured with the area under the receiver operating characteristic curve, or AUC, a standard metric where 0.5 represents random guessing and 1.0 represents perfect discrimination. In the testing set, the whole-tumor model achieved an AUC of 0.718, respectable but unremarkable. The habitat model reached 0.755 and the peritumoral model 0.758, both clearly better than the conventional approach. When features from all regions were fused, the radiomics fusion model edged up to 0.761, and after integrating clinical variables, the combined model climbed to 0.791.

The pattern in those numbers tells a story that extends well beyond thyroid surgery. The whole-tumor model, the default choice in hundreds of published radiomics studies, was the weakest performer. The improvements came precisely from the regions that conventional analysis ignores: the tumor’s internal habitats and its immediate surroundings. This is direct evidence that a tumor’s edge and its internal heterogeneity carry predictive information that the tumor’s bulk does not. It also suggests that much of the radiomics literature, by focusing narrowly on segmented tumor volumes, may be systematically leaving diagnostic signal on the table. For a field that has sometimes struggled with reproducibility and overstated claims, the incremental and transparent way these gains emerged is a point in the study’s favor.

The clinical stakes are considerable. Papillary thyroid carcinoma has an excellent overall prognosis, but lymph node metastasis is common, occurring in a substantial fraction of patients even at early stages, and it is associated with higher rates of recurrence and repeat operations. Current preoperative assessment relies on ultrasound evaluation of lymph nodes, which is operator-dependent and can miss microscopic involvement, and on fine-needle aspiration, which is invasive and subject to sampling error. Surgeons must therefore decide, often with incomplete information, whether to perform a prophylactic central neck dissection, a procedure that lengthens operations and carries risks to the recurrent laryngeal nerve and parathyroid glands. A validated preoperative tool that could stratify metastatic risk from images already acquired during routine ultrasound would allow that decision to be tailored to the individual patient rather than made by default.

The study, conducted under the Declaration of Helsinki with ethics approval from the Second Affiliated Hospital of Anhui Medical University and written informed consent from all participants, was retrospective, meaning the models were trained and tested on patients whose surgical outcomes were already known. That design is appropriate for proof of concept but leaves open the question of how the model would perform prospectively, in real time, on ultrasound machines from different manufacturers and with different scanning protocols. Radiomics features are notoriously sensitive to variations in acquisition parameters, and external validation in independent cohorts from other institutions will be essential before the approach can influence surgical planning. The authors’ testing set, held out from training, provides an honest estimate of performance, but it comes from the same hospitals and the same scanners as the training data.

There are also broader lessons here for the fast-moving field of AI-assisted imaging. The habitat subregion approach requires no additional scans, no contrast agents, and no new hardware; it simply extracts more information from images that are already collected by the millions each year. That makes it cheap, scalable, and immediately compatible with existing clinical workflows, at least in principle. The same multi-region logic could plausibly be applied to other cancers where peritumoral invasion and internal heterogeneity matter, from breast nodules to liver lesions, and several groups are already exploring habitat radiomics in those settings. If the pattern observed here holds generally, the next generation of imaging biomarkers may be defined less by what lies inside the tumor outline and more by the gradients and boundaries that pathologists have long known are where the action is.

For now, the study stands as a careful, well-structured demonstration that ultrasound images contain more than meets the eye, and that machine learning can be taught to see it. An AUC of 0.791 is good but not definitive; it is a tool to inform decisions, not replace them. Yet the trajectory is clear and the underlying insight is elegant: a tumor is not a single object but a landscape, and the most honest portrait of its dangerousness may require painting the whole landscape, from its innermost habitats to the three millimeters of normal tissue it is quietly trying to conquer. As radiomics matures from proof-of-concept papers into clinical decision support, studies like this one mark the path, showing that the future of cancer imaging may lie in looking harder at what we have been looking at all along.

Subject of Research: Multi-region ultrasound radiomics for predicting lymph node metastasis in papillary thyroid carcinoma

Article Title: Multi-region ultrasound radiomics combining whole-tumor, habitat subregionand peritumoral features for preoperative prediction of lymph node metastasis in papillary thyroid carcinoma

Article References: Multi-region ultrasound radiomics combining whole-tumor, habitat subregionand peritumoral features for preoperative prediction of lymph node metastasis in papillary thyroid carcinoma. (n.d.). https://doi.org/10.1186/s12880-026-02791-5

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02791-5

Keywords: papillary thyroid carcinoma, lymph node metastasis, ultrasound, radiomics, tumor habitat, peritumoral region, machine learning, cancer imaging, predictive medicine, tumor heterogeneity, thyroid surgery, BMC Medical Imaging

Researchers led by Enlong Zhang and Yuan Li of Peking University Third Hospital, together with colleagues at Tsinghua University Hospital and Peking University International Hospital, developed a tumor habitat-based radiomics approach to distinguish retroperitoneal non-fatty dedifferentiated liposarcoma from leiomyosarcoma. Their retrospective study included 166 patients, 102 with dedifferentiated liposarcoma and 64 with leiomyosarcoma, all of whom underwent multiphase contrast-enhanced CT. Rather than treating each tumor as a single uniform blob, the team borrowed a concept from oncology known as intratumoral heterogeneity, the recognition that a cancer is a patchwork of biologically distinct microenvironments, each with its own cellularity, vascularity, necrosis, and stromal composition.

The technical core of the method is elegantly simple. On the largest axial slice of each tumor, the researchers applied a Simple Linear Iterative Clustering algorithm, a superpixel segmentation technique originally developed for computer vision, to divide the tumor image into hundreds of small, coherent regions of similar pixel intensity. A K-means clustering step then grouped these superpixels into three habitat subregions, effectively partitioning each tumor into three zones that reflect different levels of attenuation, a radiological proxy for tissue density. The team designated these subregions ROI1, ROI2, and ROI3, with ROI2 corresponding to the intermediate-attenuation zone that often represents a transitional territory between viable cellular tissue and degenerative change.

From each habitat subregion, across three imaging phases, the non-contrast phase, the arterial phase, and the venous phase, the researchers extracted a comprehensive panel of quantitative radiomics features. These included shape descriptors such as major axis length, first-order statistics capturing the distribution of gray values, and higher-order texture features derived from gray-level co-occurrence matrices, run-length matrices, size zone matrices, dependence matrices, and neighborhood gray-tone difference matrices, as well as wavelet-transformed versions of these features that probe texture at multiple spatial scales. Feature selection was performed independently within each subregion using LASSO regression, and predictive models were then built with XGBoost, a gradient-boosted decision tree algorithm renowned for its performance on tabular biomedical data.

The results point to a clear conclusion: contrast matters. Habitat radiomics models derived from contrast-enhanced CT generally outperformed those built on non-contrast images, suggesting that the way tumor subregions take up iodinated contrast, and therefore their vascular perfusion characteristics, carries diagnostic information that plain density measurements miss. The single best-performing model was built from the venous-phase intermediate-attenuation subregion, VP-ROI2. In the testing cohort it achieved an area under the receiver operating characteristic curve of 0.834, with a 95 percent confidence interval of 0.713 to 0.950, alongside an accuracy of 0.820, a sensitivity of 0.871, and a specificity of 0.737.

The venous-phase advantage is physiologically plausible. The venous phase of a contrast-enhanced CT, typically acquired around sixty to ninety seconds after injection, captures the period of maximum enhancement in many soft-tissue tumors, when contrast has diffused into the extracellular space and reflects capillary permeability and interstitial volume. Dedifferentiated liposarcoma and leiomyosarcoma differ in their microvascular architecture and stromal composition, and those differences apparently imprint distinguishable enhancement patterns on the intermediate-attenuation habitat. Interestingly, VP-ROI2 showed only a nominally significant advantage over its non-contrast counterpart, NP-ROI2, with a P value of 0.048 that fell to an adjusted P value of 0.173 after false discovery rate correction, a statistical caution the authors appropriately acknowledge. ROI2 nevertheless emerged as the most discriminative subregion on both arterial and venous phases.

Perhaps the most compelling aspect of the study is its commitment to interpretability, a virtue not always found in machine learning medicine. Using SHAP, or SHapley Additive exPlanations, a game-theoretic framework that quantifies each feature’s contribution to individual predictions, the team identified original_shape_MajorAxisLength and wavelet-based texture features as the most influential predictors. Shape matters, which makes intuitive sense: dedifferentiated liposarcomas and leiomyosarcomas differ in their growth patterns and margins. But the prominence of wavelet texture features, which encode fine-scale spatial patterning of pixel intensities, indicates that the microscopic organization of tumor tissue, its heterogeneity at radiologically invisible scales, is what truly separates the two diagnoses. The models were built and reported following established standards, including the Image Biomarker Standardization Initiative nomenclature and the TRIPOD guidelines for prediction model reporting, and the study received an assessment of radiomics quality.

The clinical implications are significant. Today, distinguishing these sarcomas preoperatively often depends on biopsy, and even then core needle sampling of a large heterogeneous tumor can miss the diagnostic territory, a problem known as sampling error. Accurate preoperative differentiation guides the surgical plan: dedifferentiated liposarcoma demands wide clearance of the fatty component along with the dedifferentiated nodule, whereas leiomyosarcoma management hinges more on vascular involvement and multimodal planning. A noninvasive imaging biomarker that can flag the likely diagnosis before the first incision could help surgeons counsel patients, select neoadjuvant strategies, and design clinical trials that stratify patients by histological subtype rather than by the blunt label of retroperitoneal sarcoma.

The authors are careful to frame this as a promising step rather than a finished clinical tool. The cohort was retrospective and drawn from Chinese hospitals, the tumors were segmented on the largest axial slice rather than in three dimensions, and the performance figures, while respectable, leave room for improvement before the model could stand beside pathology. External validation in independent, multiethnic cohorts and prospective testing will be essential before VP-ROI2-based habitat radiomics enters routine decision-making. Still, the study offers a vivid demonstration of a broader idea now sweeping through oncological imaging: that every tumor is a landscape of habitats, and that the map of that landscape, drawn automatically from a routine contrast-enhanced CT scan, may hold answers that biopsies, radiologists, and even pathologists struggle to provide. The venous phase, long treated as a routine addendum to the arterial spectacle, turns out to be where the sarcomas reveal their secrets.

Subject of Research: Venous-phase CT-based tumor habitat radiomics for differentiating retroperitoneal non-fatty dedifferentiated liposarcoma from leiomyosarcoma

Article Title: Venous-phase CT-based tumor habitat radiomics for differentiating retroperitoneal non-fatty dedifferentiated liposarcoma from leiomyosarcoma

Article References: Zhang, E., Li, Y., Ma, L., Ji, D., Zhang, M., & Lang, N. (2026). Venous-phase CT-based tumor habitat radiomics for differentiating retroperitoneal non-fatty dedifferentiated liposarcoma from leiomyosarcoma. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02784-4

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02784-4

Keywords: retroperitoneal sarcoma, dedifferentiated liposarcoma, leiomyosarcoma, radiomics, tumor habitat, intratumoral heterogeneity, computed tomography, machine learning, XGBoost, SHAP, cancer imaging, preoperative diagnosis